Primary hyperparathyroidism: Is vitamin D supplementation safe?

Australian Family Physician

Volumn 40, Issue 11, 2011, Pages 881-884

  Rankin, Wayne ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Primary hyperparathyroidism; Vitamin D

Indexed keywords

VITAMIN; VITAMIN D;

ARTICLE; BLOOD; DIET SUPPLEMENTATION; HUMAN; PRIMARY HYPERPARATHYROIDISM; RISK FACTOR; VITAMIN D DEFICIENCY;

DIETARY SUPPLEMENTS; HUMANS; HYPERPARATHYROIDISM, PRIMARY; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84856005943     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bosomworth NJ. Mitigating epidemic vitamin D deficiency: the agony of evidence. Can Fam Physician 2011;57:16-20.
2. Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc 2010;85:752-7.
3. M orris HA. Vitamin D: a hormone for all seasons - how much is enough? Clin Biochem Rev 2005;26:21-32.
4. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007;85:6-18.
5. Fraser WD. Hyperparathyroidism. Lancet 2009;374:145-58.
6. Pallan S, Khan A. Primary hyperparathyroidism: Update on presentation, diagnosis, and management in primary care. Can Fam Physician 2011;57:184-9.
7. Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 2007;92:3001-5.
8. S ilverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009;94:351-65.
9. Lundgren E, Hagström EG, Lundin J, et al. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago. World J Surg 2002;26:931-6.
10. Rao DS, Honasoge M, Divine GW, et al. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 2000;85:1054-8.
11. Moosgaard B, Christensen SE, Vestergaard P, Heickendorff L, Christiansen P, Mosekilde L. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin Endocrinol (Oxf) 2008;68:707-15.
12. S tein EM, Dempster DW, Udesky J, et al. Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism. Bone 2011;48:557-61.
13. Grey A, Lucas J, Horne A, Gamble G, Davidson JS, Reid IR. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab 2005;90:2122-6.
14. Howlett TA, Levy MJ. Endocrine disease. In: Kumar P, Clark M, editors. Clinical medicine. 7th edn. London: Elsevier, 2009;953-1028.
15. Australian Medicines Handbook. Chapter 10-ndocrine drugs. Available at www.amh.net.au/online/view. php?page=chapter10/class2vitamin-d-substances.html [Accessed 23 April 2011].
16. Souberbielle JC, Maury E, Friedlander G, Cormier C. Vitamin D and primary hyperparathyroidism (PHPT). J Steroid Biochem Mol Biol 2010;121:199-203.
17. Kleeman CR, Norris K, Coburn JW. Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient? Miner Electrolyte Metab 1987;13:305-10.
18. Eastell R, Arnold A, Brandi ML, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009;94:340-50.
19. Kantorovich V, Gacad MA, Seeger LL, Adams JS. Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism. J Clin Endocrinol Metab 2000;85:3541-3.
20. Grubbs EG, Rafeeq S, Jimenez C, et al. Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? Surgery 2008;144:852-8.
21. Tucci JR. Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D. Eur J Endocrinol 2009;161:189-93.
22. Isidro ML, Ruano B. Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency. Endocrine 2009;36:305-10.
23. Velayoudom-Cephise FL, Foucan L, Soudan B, et al. La moitié des patients atteints d'hyperparathyroïdies primaires ont un déficit en vitamine D aggravant l'atteinte osseuse. Presse Med 2011;40:e120-7.
24. Hackman KL, Gagnon C, Briscoe RK, Lam S, Anpalahan M, Ebeling PR. Efficacy and safety of oral continuous lowdose versus short-term high-dose vitamin D: a prospective randomised trial conducted in a clinical setting. Med J Aust 2010;192:686-9.
25. Papaioannou A, Kennedy CC, Giangregorio L, et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskelet Disord 2011;12:135